bibliographic resource 5328417 [br/5328417]
https://w3id.org/oc/corpus/br/5328417

is a

• document
• article

title

• Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

publication date

• 2009-01-01

contributor

• https://w3id.org/oc/corpus/ar/20814529
• https://w3id.org/oc/corpus/ar/20814530
• https://w3id.org/oc/corpus/ar/20814531
• https://w3id.org/oc/corpus/ar/20814532
• https://w3id.org/oc/corpus/ar/20814533
• https://w3id.org/oc/corpus/ar/20814534
• https://w3id.org/oc/corpus/ar/20814535
• https://w3id.org/oc/corpus/ar/20814536
• https://w3id.org/oc/corpus/ar/20814537
• https://w3id.org/oc/corpus/ar/20814538
• https://w3id.org/oc/corpus/ar/20814539
• https://w3id.org/oc/corpus/ar/20814540
• https://w3id.org/oc/corpus/ar/20814541
• https://w3id.org/oc/corpus/ar/20814542
• https://w3id.org/oc/corpus/ar/20814543
• https://w3id.org/oc/corpus/ar/20814544
• https://w3id.org/oc/corpus/ar/20814545
• https://w3id.org/oc/corpus/ar/20814546

format

• https://w3id.org/oc/corpus/re/3066443

identifier

• https://w3id.org/oc/corpus/id/10859040
• https://w3id.org/oc/corpus/id/10859041
• https://w3id.org/oc/corpus/id/10859042
• https://w3id.org/oc/corpus/id/10859043

part of

• https://w3id.org/oc/corpus/br/208653